Over half of large US employers plan to cut health benefits in 2026 as rising costs of weight-loss drugs like Wegovy drive up ...

British Columbia's Health Ministry is limiting the sales of two more diabetes drugs to curb their off-label use for weight ...

Union trustees allege health plan documents didn’t allow for $4.3 million in drug spending that was cleared by pharmacy ...

Lawmakers are trying to restore access to GLP-1 weight loss drugs, like Ozempic and Wegovy, after Ohio removed medical ...

According to the Centers for Disease Control and Prevention (CDC), approximately 42% of Americans are obese, and 65% say ...

NEW YORK (Reuters) -More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from weight-loss and specialty drugs squeeze budgets, according to a new ...

Drug development is a decade-long, costly process replete with failures. If we don’t incentivize investments in research and ...

Three studies presented today at the Society of NeuroInterventional Surgery's (SNIS) 22nd Annual Meeting discussed whether ...

Weight fluctuation happens daily, week to week, or month to month. Learn about causes and when to see a healthcare provider ...

New and disturbing concerns about fake GLP-1 drugs are cited in a letter sent to the FDA by Tennessee officials, including Sen. Marsha Blackburn.